Literature DB >> 21324361

"Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease.

Nigel I Wood1, Dervila Glynn, A Jennifer Morton.   

Abstract

Environmental enrichment (EE) has been shown to improve neurological function and cognitive performance in animal models of Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). We have shown recently that even when they are already living in an enriched environment, additional EE had beneficial effects in R6/2 mice. Here we examined the effects of three different enrichment paradigms on cognitive dysfunction in R6/2 mice in a longitudinal study. The EE consisted of either enforced physical exercise on the Rotarod (predominantly motor stimulation), training in a novel type of maze, the 'noughts and crosses' (OX) maze (mainly cognitive stimulation), or access to a playground, that gave the mice the opportunity for increased, self-motivated activity using running wheels and other toys in a social context (mixed EE). We designed the OX maze to test spatial memory in the R6/2 mouse while minimizing motor demands. Control mice remained in their home cages during the training period. Mice were given enrichment between 6 and 8 weeks of age, followed by cognitive (Lashley maze) and motor testing (Rotarod) between 8 and 10 weeks. Mice were then given a further period of enrichment between 10 and 12 weeks, and their behavior was re-tested between 12 and 14 weeks of age. We also collected body weights and age at death from all mice. The OX maze was as sensitive for detecting learning deficits in the R6/2 mice as other types of mazes (such as the Morris water maze). Interestingly, providing cognitive stimulation via training in the OX maze produced significant improvements in subsequent cognitive performance by male, but not female, R6/2 mice in the Lashley maze task. OX maze training also significantly improved loss of body weight and survival in male R6/2 mice. These effects became apparent after as little as 2 weeks of training in the OX maze. These data suggest that there is a cognitive reserve that may be exploited in neurodegenerative disease. While brain training was not beneficial for all mice, it produced no deleterious effects, and so warrants further study in rodent models of HD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324361     DOI: 10.1016/j.nbd.2011.02.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  26 in total

Review 1.  What is comparable in comparative cognition?

Authors:  Lars Chittka; Stephen J Rossiter; Peter Skorupski; Chrisantha Fernando
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-10-05       Impact factor: 6.237

2.  Energy drinks and their component modulate attention, memory, and antioxidant defences in rats.

Authors:  M T Costa Valle; N S Couto-Pereira; C Lampert; D M Arcego; A P Toniazzo; R P Limberger; E Dallegrave; C Dalmaz; M D Arbo; M B Leal
Journal:  Eur J Nutr       Date:  2017-08-12       Impact factor: 5.614

3.  Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Authors:  George V Rebec
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

4.  Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease.

Authors:  Nigel I Wood; Stephen J Sawiak; Guido Buonincontri; Youguo Niu; Andrew D Kane; T Adrian Carpenter; Dino A Giussani; A Jennifer Morton
Journal:  J Huntingtons Dis       Date:  2012

Review 5.  Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.

Authors:  Pawel M Switonski; Wojciech J Szlachcic; Agnieszka Gabka; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2012-09-04       Impact factor: 5.590

6.  In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model.

Authors:  Jessica J Steventon; David J Harrison; Rebecca C Trueman; Anne E Rosser; Derek K Jones; Simon P Brooks
Journal:  J Huntingtons Dis       Date:  2015

7.  Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice.

Authors:  Thibault Renoir; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  PLoS Curr       Date:  2011-11-08

8.  Onset and progression of behavioral and molecular phenotypes in a novel congenic R6/2 line exhibiting intergenerational CAG repeat stability.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Stephan Grueninger; Lisa A Yuva-Paylor; Arsalan U Syed; Andreas Weiss; Richard Paylor
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

9.  Right ventricular dysfunction in the R6/2 transgenic mouse model of Huntington's disease is unmasked by dobutamine.

Authors:  Guido Buonincontri; Nigel I Wood; Simon G Puttick; Alex O Ward; T Adrian Carpenter; Stephen J Sawiak; A Jennifer Morton
Journal:  J Huntingtons Dis       Date:  2014

10.  Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration.

Authors:  Elisa Scheller; Ahmed Abdulkadir; Jessica Peter; Sarah J Tabrizi; Richard S J Frackowiak; Stefan Klöppel
Journal:  Neuroimage       Date:  2013-03-14       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.